Safe Orthopaedics launches SORA, a virtual operating room assistant
by CM Staff
SORA intends to automatically manage the inventory, traceability, and replenishment of Safe Orthopaedics products and allow virtual assistance of operating room teams.
ÉRAGNY-SUR-OISE — Safe Orthopaedics, a company specializing in the design, manufacturing and marketing of single-use technologies for spinal surgeries, announces the launch of the Safe Operating Room Assistant (SORA). A first for the Orthopaedics market, SORA intends to automatically manage the inventory, traceability, and replenishment of Safe Orthopaedics products and allow virtual assistance of operating room teams.
Safe Orthopaedics has developed a ready-to-use technologies model which has helped optimize the surgical process, as published by the Kremlin-Bicètre and Saint Etienne hospitals. Based on customers’ requests, Safe Orthopaedics has designed and validated its first generation of SORA. This medical trolley stores Safe Orthopaedics devices, and is equipped with a web-connected touch-screen and can be transferred from storage areas to the operating room for offering three main functions:
- Assisted selection of implants & instruments in the operating room: Via the touch-screen and proprietary software developed by Safe Orthopaedics, the medical staff will choose the product as needed in the operating room. SORA selects and delivers the correct instrumentation and implants, avoiding product selection errors.
- Virtual assistance of surgeons and medical staff: The surgical documentation of all technologies contained into SORA is accessible through the software and on-line assisted surgical support.
- Automatic replenishment of devices and support of inventory management: SORA’s automated ordering processes expects to reduce the lead-time of delivery after each surgery, improve surgery planning and reduce the hospitals logistics times, resources and costs.
Safe Orthopaedics targets early 2021 for a beta launch in a limited number of strategic centres in Europe and the USA for validation. In parallel with the evaluation, Safe Orthopaedics is preparing the worldwide launch in the coming 12-18 months and plan the development of new clinical functionalities in the coming years.
